Frontiers in Oncology Seminars

Integrated Radiogenomics For Treatment
Monitoring In High Grade Serous Ovarian
Cancer

Evis Sala, MD, PhD, FRCR
Tuesday,  February 2, 2021

Evis Sala is the Professor of Oncological Imaging at the University of Cambridge, United Kingdom (UK) and co-leads the Cancer Research UK Cambridge Centre Advanced Cancer Imaging Programme and the Integrated Cancer Medicine Programme. Dr Sala’s research focuses on the development and validation of functional imaging biomarkers to rapidly evaluate treatment response using physiologic and metabolic tumour habitat imaging. Her research in the field of radiogenomics has focused on understanding the molecular basis of cancer by demonstrating the phenotypic patterns which occur as a result of multiple genetic alterations that interact with the tumour microenvironment to drive the disease in several tumour types. Her work integrates quantitative imaging methods for evaluation of spatial and temporal tumour heterogeneity with genomics, proteomics and metabolomics. She is also leading multiple research projects focusing on the development and implementation of artificial intelligence methods for image reconstruction, segmentation, and data integration. Dr Sala is an outstanding educator, orator and mentor. In recognition for her contribution to education and research in oncological imaging she received the Radiology Society of North America (RSNA) Honoured Educator Award in 2014, 2017 and 2020. Her leadership extends to the most important international bodies in the field, as Chair of the RSNA Oncologic Imaging Track, Fellow of the International Cancer Imaging Society, Fellow of the International Society for Magnetic Resonance in Medicine and Fellow of the European Society of Urogenital Radiology.